Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
Nephrol Dial Transplant
    April 2026
  1. TSENG MH, Sung CC, Cheng CJ, Tsai JD, et al
    Phenotype and renal outcomes of patients with congenital arginine vasopressin resistance.
    Nephrol Dial Transplant. 2026;41:909-918.
    >> Share

  2. DORICIC J, Greite R, Brasen JH, Schmidt-Ott K, et al
    Neutrophil infiltration of kidney grafts: incidence, associated factors and graft survival.
    Nephrol Dial Transplant. 2026;41:919-929.
    >> Share

  3. ZADORA W, Jacobs E, Lauriola M, Dejongh S, et al
    Intestinal Barrier Dysfunction in Chronic Kidney Disease: Evidence, Mechanisms, and its Potential Clinical Implications.
    Nephrol Dial Transplant. 2026 Apr 20:gfag082. doi: 10.1093.
    >> Share

  4. IDOWU A, Lo KB, Mathew R, Navaneethan SD, et al
    Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney Disease.
    Nephrol Dial Transplant. 2026 Apr 15:gfag087. doi: 10.1093.
    >> Share

    March 2026
  5. OMIC H, Mahdi-Nour-Ali Y, Hoffmann S, Abd El-Ghany K, et al
    Prevalence of Strongyloides stercoralis in haemodialysis patients in Vienna.
    Nephrol Dial Transplant. 2026;41:669-680.
    >> Share

  6. MEKRAKSAKIT P, Vargas-Brochero MJ, Russo I, Buglioni A, et al
    Monoclonal gammopathy associates with kidney failure in ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2026;41:692-702.
    >> Share

  7. BAOUCHE H, Couchoud C, Moranne O, Kwon T, et al
    Children born to mothers receiving chronic dialysis, a national French cohort (2013-2021).
    Nephrol Dial Transplant. 2026 Mar 20:gfag029. doi: 10.1093.
    >> Share

  8. MURUNGA S, Hofstetter J, Bayazit AK, Duzova A, et al
    Urinary Albumin-to-Creatinine Associates More Closely than Protein-to-Creatinine Ratio with Kidney Outcomes in Pediatric Chronic Kidney Disease.
    Nephrol Dial Transplant. 2026 Mar 14:gfag061. doi: 10.1093.
    >> Share

  9. KIM JE, Kang D, Song SM, Kang MW, et al
    Clinical impact of ionized calcium and hidden hypocalcemia on cardiovascular outcomes in dialysis patients.
    Nephrol Dial Transplant. 2026 Mar 13:gfag057. doi: 10.1093.
    >> Share

  10. ALAMO BS, Minguez I, Dominguez MED, Mendiola NR, et al
    The deleterous effect of proteinuria in residual kidney function in hemodialysis patients.
    Nephrol Dial Transplant. 2026 Mar 13:gfag058. doi: 10.1093.
    >> Share

  11. REIS T, Cantaluppi V, Ostermann M, Brendolan A, et al
    Hemoadsorption Combined with Hemodialysis (HAHD): a Consensus Statement from an International Expert Panel.
    Nephrol Dial Transplant. 2026 Mar 3:gfag046. doi: 10.1093.
    >> Share

    February 2026
  12. ORTIZ A, Lees JS, Torra R, Stel VS, et al
    The updated global burden of chronic kidney disease: one death every 20 seconds.
    Nephrol Dial Transplant. 2026 Feb 25:gfag040. doi: 10.1093.
    >> Share

    January 2026
  13. FOUQUE D, Koppe L
    Oil supplementation and cardiovascular mortality in the dialysis population.
    Nephrol Dial Transplant. 2026 Jan 28:gfag015. doi: 10.1093.
    >> Share

  14. DEL VECCHIO L, Cases A, Eisenga MF, Malyszko J, et al
    KDIGO 2026 clinical practice guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP).
    Nephrol Dial Transplant. 2026 Jan 28:gfag014. doi: 10.1093.
    >> Share

  15. BOUWMANS P, Clase CM, Carrero JJ
    Drug stewardship for RAS-inhibitors and SGLT2-inhibitors in chronic kidney disease: stay on, restart.
    Nephrol Dial Transplant. 2026 Jan 22:gfag008. doi: 10.1093.
    >> Share

  16. WANG Y, Zhu L, Yang Y, You Z, et al
    Association between body roundness index and all-cause and cardiovascular disease mortality in maintenance hemodialysis patients: evidence from a prospective cohort study in Southern China.
    Nephrol Dial Transplant. 2026 Jan 21:gfag006. doi: 10.1093.
    >> Share

  17. RINCON-AREVALO H, Halleck F, Boger D, Rosenlehner E, et al
    RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls.
    Nephrol Dial Transplant. 2026 Jan 13:gfag002. doi: 10.1093.
    >> Share

    December 2025
  18. MEIJERS B, Shroff R, Battaglia Y, Kazancioglu R, et al
    Medical device regulation and dialysis practice - impact on patients, doctors and manufacturers.
    Nephrol Dial Transplant. 2025 Dec 29:gfaf269. doi: 10.1093.
    >> Share

  19. BELLIZZI V, Fordellone M, De Nicola L, Minutolo R, et al
    Cost-effectiveness of protein restricted diets in advanced CKD.
    Nephrol Dial Transplant. 2025;41:149-160.
    >> Share

  20. MAUFRAIS C, Josse M, Patrier L, Isnard M, et al
    Cardioprotection from intradialytic exercise: a randomized trial.
    Nephrol Dial Transplant. 2025;41:67-78.
    >> Share

  21. FERREIRA AC, Sezer S, Palladino G, Ortiz A, et al
    Safeguarding Innovation in Dialysis-Rethinking the EU Medical Device Regulation.
    Nephrol Dial Transplant. 2025 Dec 22:gfaf270. doi: 10.1093.
    >> Share

  22. MA LY, Tu YR, Chan MJ, Chan CI, et al
    The effect of icodextrin on peritoneal dialysis patients with congestive heart failure: a time-varying exposure design and target trial emulation approach.
    Nephrol Dial Transplant. 2025 Dec 13:gfaf265. doi: 10.1093.
    >> Share

    November 2025
  23. CASAL MOURA M, Patricio-Liebana M, Zand L, Zubidat D, et al
    Sex-specific clinical presentations and outcomes in ANCA-associated vasculitis presenting with severe kidney disease.
    Nephrol Dial Transplant. 2025;40:2359-2371.
    >> Share

  24. MIAO J, Zand J, Vaughan L, Soler MJ, et al
    Clinical phenotypes and renal outcomes in PLA2R-associated membranous nephropathy: a multi-center cohort study with unsupervised cluster analysis.
    Nephrol Dial Transplant. 2025;40:2309-2318.
    >> Share

  25. ZHANG F, Huang L, Zhong Y
    Serum sodium levels and risk of all-cause mortality among hospitalized patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Nov 26:gfaf255. doi: 10.1093.
    >> Share

  26. WOUDA RD, Karsten M, Michels EHA, Garrelds IM, et al
    Natriuretic Response to an Acute Oral Potassium Load in Healthy Individuals and Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Nephrol Dial Transplant. 2025 Nov 25:gfaf238. doi: 10.1093.
    >> Share

  27. KOPYTINA V, Marchant V, Rodrigues-Diez R, Pascual-Anton L, et al
    Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.
    Nephrol Dial Transplant. 2025 Nov 13:gfaf249. doi: 10.1093.
    >> Share

  28. YANG C, Liao B, Vart P, Johnson DW, et al
    Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox.
    Nephrol Dial Transplant. 2025 Nov 8:gfaf237. doi: 10.1093.
    >> Share

    October 2025
  29. SATISH P, Smith R, Alasadi A, Frackiewicz E, et al
    A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality.
    Nephrol Dial Transplant. 2025;40:2159-2168.
    >> Share

  30. SIM JJ, Chen Q, Cannizzaro N, Fernandes AW, et al
    CKD progression, kidney failure, and mortality among US patients with IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:2104-2117.
    >> Share

  31. VIRAMONTES-HORNER D, Stewart P, Stewart J, Taal MW, et al
    A novel system to continuously estimate intradialytic blood pressure in real time.
    Nephrol Dial Transplant. 2025;40:2074-2080.
    >> Share

  32. MORALES E, Jenssen TG, Bevc S, Miglinas M, et al
    Obesity as a modifiable risk factor in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Oct 30:gfaf231. doi: 10.1093.
    >> Share

  33. HEERSPINK HJL, van Raalte DH, Bjornstad P, Bunck MC, et al
    Rationale, Design, and Baseline Characteristics of the TRANSCEND-CKD trial of Retatrutide in Patients with Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Oct 29:gfaf230. doi: 10.1093.
    >> Share

  34. LOPEZ KC, Weidmann L, Harmacek D, Roessler F, et al
    Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.
    Nephrol Dial Transplant. 2025 Oct 22:gfaf224. doi: 10.1093.
    >> Share

  35. TIAN Z, Hillebrand UC, Casper J, Schmidt-Ott KM, et al
    Chronic kidney disease confers increased excess risks of mortality and cardiovascular events in women compared to men.
    Nephrol Dial Transplant. 2025 Oct 16:gfaf217. doi: 10.1093.
    >> Share

  36. TEOH STY, Yap DYH, Tang CSO, Chan TM, et al
    Chronic Kidney Disease G3-5 in Lupus Nephritis - Prevalence, Progression, and Risk Factors.
    Nephrol Dial Transplant. 2025 Oct 3:gfaf201. doi: 10.1093.
    >> Share

    September 2025
  37. CHUANG MH, Wang HY, Kan WC, Chien CC, et al
    Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD.
    Nephrol Dial Transplant. 2025;40:1897-1905.
    >> Share

  38. ANDRE DE LA RAMBELJE M, Beldhuis IE, Heerspink HJL, Greasley PJ, et al
    Protein profiles and associated biological pathways among different etiologies of chronic kidney disease: new insights from DAPA-CKD.
    Nephrol Dial Transplant. 2025 Sep 8:gfaf180. doi: 10.1093.
    >> Share

    August 2025
  39. SLON-ROBLERO MF, Stel VS, Sanchez-Alvarez E, Escola JM, et al
    Trends in Home Dialysis Over the Last Decade in Europe: an ERA Registry Study.
    Nephrol Dial Transplant. 2025 Aug 29:gfaf171. doi: 10.1093.
    >> Share

  40. ATIQUZZAMAN M, Er L, Djurdjev O, Zheng Y, et al
    COVID-19 infection and the progression of kidney disease in British Columbia, Canada.
    Nephrol Dial Transplant. 2025;40:1717-1726.
    >> Share

  41. CASINO FG, Casino A, Herva ET, Basile C, et al
    New formulas for calculating dialysis dose in incremental haemodialysis.
    Nephrol Dial Transplant. 2025 Aug 7:gfaf147. doi: 10.1093.
    >> Share

  42. BATTAGLIA Y, Shroff R, Meijers B, Nistor I, et al
    Haemodiafiltration versus high-flux haemodialysis-a Consensus Statement from the EuDial Working Group of the ERA.
    Nephrol Dial Transplant. 2025;40:1590-1614.
    >> Share

  43. YAO YX, Tang C, Shi SF, Chen P, et al
    Red blood cell casts on kidney biopsy and progression of IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:1570-1579.
    >> Share

  44. YOSHIDA M, Maeoka Y, Takahashi A, Ishiuchi N, et al
    Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis.
    Nephrol Dial Transplant. 2025;40:1538-1549.
    >> Share

  45. PAGNIEZ MS, Fages V, Gatinois C, Larrue R, et al
    Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome.
    Nephrol Dial Transplant. 2025;40:1522-1530.
    >> Share

    July 2025
  46. PERIS-FERNANDEZ M, Roca-Marugan MI, Viejo-Boyano I, Soldevila-Orient A, et al
    Hemodialysis removes protective metabolites and disrupts mitochondrial function.
    Nephrol Dial Transplant. 2025 Jul 31:gfaf145. doi: 10.1093.
    >> Share

  47. ZOCCALI C, Chinnappa S, Fernandez-Fernandez B, Iatridi F, et al
    Myocardial Ischaemic Syndromes in Chronic Kidney Disease: Risky Pathways from Non-Acute to Acute Events.
    Nephrol Dial Transplant. 2025 Jul 30:gfaf142. doi: 10.1093.
    >> Share

  48. AOUN M, Combe C, Jadoul M
    Life Support in Hemodialysis Emergencies - Treatment standard.
    Nephrol Dial Transplant. 2025 Jul 15:gfaf136. doi: 10.1093.
    >> Share

  49. COX EF, Gullapudi VRL, Buchanan CE, White K, et al
    Effect of haemodialysis on the brain and heart assessed using multiparametric MRI.
    Nephrol Dial Transplant. 2025 Jul 9:gfaf117. doi: 10.1093.
    >> Share

  50. BONIFANT G, Davis SN, Weir MR
    Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf083. doi: 10.1093.
    >> Share

  51. LAVILLE SM, Mouheb A, Massy ZA, Jacquelinet C, et al
    Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf125. doi: 10.1093.
    >> Share

  52. GUERRA JMA, Martinez-Martinez JI
    Multifactorial chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf122. doi: 10.1093.
    >> Share

  53. CHERNEY DZI, Belmar N, Bjornstad P, Chacko MM, et al
    Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 3:gfaf114. doi: 10.1093.
    >> Share

    June 2025
  54. MARENGO M, Migliori M, Merlotti G, Naso E, et al
    High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia.
    Nephrol Dial Transplant. 2025 Jun 6:gfaf101. doi: 10.1093.
    >> Share


  55. Correction to: Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jun 5:gfaf099. doi: 10.1093.
    >> Share

  56. HALBRITTER J, Figueres L, Van Eerde AM, Capasso G, et al
    Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.
    Nephrol Dial Transplant. 2025 Jun 3:gfaf092. doi: 10.1093.
    >> Share

    May 2025
  57. WANG Z, Xiang W, Wang Y, Yu J, et al
    Patients with membranous lupus nephritis form two clusters with different prognoses.
    Nephrol Dial Transplant. 2025;40:1213-1224.
    >> Share

  58. SHEN X, Chen P, Liu M, Liu L, et al
    Long-term outcomes of IgA nephropathy in China.
    Nephrol Dial Transplant. 2025;40:1137-1146.
    >> Share

  59. MORALES E, Martin WP, Bevc S, Jenssen TG, et al
    How to individualise renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.
    Nephrol Dial Transplant. 2025 May 13:gfaf069. doi: 10.1093.
    >> Share

  60. ZOCCALI C, Lameire N, Ronco C, Carlson N, et al
    Acute kidney injury, acute kidney disease, and chronic kidney disease: challenges and research perspectives.
    Nephrol Dial Transplant. 2025 May 12:gfaf090. doi: 10.1093.
    >> Share

  61. GLASSOCK RJ, Rule AD, Denic A, Delanaye P, et al
    KIDNEY AGING and CHRONIC KIDNEY DISEASE - Another Perspective.
    Nephrol Dial Transplant. 2025 May 7:gfaf087. doi: 10.1093.
    >> Share


  62. Correction to: Global health inequalities of chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2025 May 6:gfaf080. doi: 10.1093.
    >> Share

    April 2025
  63. QUENNEPOIX M, Koppe L, Bevier A, Barba C, et al
    Comparison of different heparin-free dialysis methods.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf082. doi: 10.1093.
    >> Share

  64. SCHMIDT-LAUBER C, Thompson C, Schmidt EA, Klopp A, et al
    Prevalence and Characteristics of Chronic Kidney Disease in the Hamburg City Health Study.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf075. doi: 10.1093.
    >> Share

  65. HAUPENTHAL F, Doberer K, Kapps S, Klager J, et al
    Self-reported Non-adherence to Immunosuppressive Medication Detected by the BAASIS Predicts Allograft Rejections in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 28:gfaf078. doi: 10.1093.
    >> Share

  66. YEPES-CALDERON M, Martin Del Campo Sanchez F, Kremer D, Knobbe TJ, et al
    Plasma Trimethylamine N-oxide Concentration and All-Cause Mortality in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 24:gfaf071. doi: 10.1093.
    >> Share

  67. DOLAN KJ, Gist KM, Basalely A, Bottari G, et al
    Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry.
    Nephrol Dial Transplant. 2025 Apr 21:gfaf067. doi: 10.1093.
    >> Share

  68. KANBAY M, Abdel-Rahman SM, Brinza C, Ozbek L, et al
    A Meta-analysis of Graft Survival, Patient Survival, and Delayed Graft Function in First-Time and Repeat Kidney Transplants.
    Nephrol Dial Transplant. 2025 Apr 15:gfaf066. doi: 10.1093.
    >> Share

  69. MONTEZ DE SOUSA IR, Bonthuis M, Kramer A, Ordonez FA, et al
    Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.
    Nephrol Dial Transplant. 2025;40:707-719.
    >> Share

    March 2025
  70. AGRAWAL R, Waller JL, Baer SL, Bollag WB, et al
    Psoriaisis associates with increased risk for kidney transplant rejection.
    Nephrol Dial Transplant. 2025 Mar 26:gfaf047. doi: 10.1093.
    >> Share

  71. ZHAO Y, Yang K, Nguyen CM, Wu H, et al
    Sex-specific cardiac dysfunction in mice with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Mar 21:gfaf056. doi: 10.1093.
    >> Share

  72. FERRO CJ, Wanner C, Luyckx V, Stevens K, et al
    ABCDE to identify and prevent chronic kidney disease: a call to action.
    Nephrol Dial Transplant. 2025 Mar 19:gfaf057. doi: 10.1093.
    >> Share

  73. ANDRADE A, Bachmann M, Bobot M, Bruchfeld A, et al
    Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  74. PEPIN M, Giannakou K, Levassort H, Farinha A, et al
    Care pathways for patients with cognitive impairment and chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  75. ZHANG Y, Ye Z, Zhang Y, Yang S, et al
    Dietary vitamin E and tocopherol isoform intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf052. doi: 10.1093.
    >> Share

  76. BAKKER WM, Heerspink HJL, Berger SP, Wanner C, et al
    Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf046. doi: 10.1093.
    >> Share

    February 2025
  77. URO-COSTE C, Lambert C, Audard V, Couzi L, et al
    Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft.
    Nephrol Dial Transplant. 2025;40:475-483.
    >> Share

  78. PREKA E, Bonthuis M, Marks SD, Kramer A, et al
    Access to kidney transplantation and re-transplantation from childhood to adulthood: long-term data from the ERA Registry.
    Nephrol Dial Transplant. 2025 Feb 12:gfaf025. doi: 10.1093.
    >> Share

  79. KANDURI SR, Badari A, Ullah F, Yang CW, et al
    Recovery from acute kidney injury treated with dialysis in patients with multiple myeloma treated with proteasome inhibitors.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf028. doi: 10.1093.
    >> Share

  80. XU H, Eriksdotter M, Hafez G, Mitra S, et al
    Cholinergic system in patients with chronic kidney disease: cognitive and renal implications.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf029. doi: 10.1093.
    >> Share

  81. AGARWAL R, Green JB, Heerspink HJL, Mann JFE, et al
    COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf022. doi: 10.1093.
    >> Share

  82. WAGNER CA
    Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  83. ALICIC RZ, Neumiller JJ, Tuttle KR
    Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  84. NEUEN BL, Yeung EK, Rangaswami J, Vaduganathan M, et al
    Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  85. ZHU D, Judge PK, Staplin N, Haynes R, et al
    Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  86. NARDONE M, Yau K, Kugathasan L, Odutayo A, et al
    Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  87. MOEDT E, Wasehuus VS, Heerspink HJL
    Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  88. CHEIKH HASSAN H, Tunnicliffe DJ, Loyd L, Mullan A, et al
    Kidney failure from kidney stones: an ANZDATA study.
    Nephrol Dial Transplant. 2025;40:320-328.
    >> Share

    January 2025
  89. JORGENSEN HS, Vervloet M, Cavalier E, Bacchetta J, et al
    The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation - a European consensus statement.
    Nephrol Dial Transplant. 2025 Jan 28:gfae293. doi: 10.1093.
    >> Share

  90. TORINO C, Mallamaci F, Tripepi R, Mezzatesta S, et al
    The use of lung-ultrasound monitoring and the risk of intradialysis hypotension in hemodialysis patients: an analysis in the context of a randomized clinical trial.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf015. doi: 10.1093.
    >> Share

  91. ZOCCALI C, Mallamaci F, Kanbay M, Tuttle KR, et al
    The Autonomic Nervous System and Inflammation in Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf020. doi: 10.1093.
    >> Share

  92. YEN FS, Wei JC, Cheng WY, Huang CT, et al
    Low birth weight and chronic kidney disease with progression to kidney failure in children.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf018. doi: 10.1093.
    >> Share

    December 2024
  93. FRIEDRICH J, Bellmann M, Klank D, Porubsky S, et al
    Clinical and histological comparison of IgA nephritis and renal IgA vasculitis.
    Nephrol Dial Transplant. 2024;40:182-192.
    >> Share

  94. BUTZ E, Schultheiss UT, Sekula P
    Modeling heterogeneity in the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Dec 19:gfae288. doi: 10.1093.
    >> Share

  95. GANSEVOORT RT, Wheeler DC, Deben FM, Speeckaert M, et al
    The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial.
    Nephrol Dial Transplant. 2024 Dec 3:gfae261. doi: 10.1093.
    >> Share

    November 2024
  96. AKIFOVA A, Budde K, Amann K, Buettner-Herold M, et al
    Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.
    Nephrol Dial Transplant. 2024 Nov 29:gfae282. doi: 10.1093.
    >> Share

  97. HAHN LUNDSTROM U, Ramspek CL, Dekker FW, van Diepen M, et al
    Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
    Nephrol Dial Transplant. 2024;39:2079-2087.
    >> Share

  98. SUENAGA T, Tanaka S, Kitamura H, Tsuruya K, et al
    Estimated potassium intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 27:gfae277. doi: 10.1093.
    >> Share

  99. DASGUPTA I, Meadowcroft AM, Bhatt PR, Acharya A, et al
    Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.
    Nephrol Dial Transplant. 2024 Nov 21:gfae273. doi: 10.1093.
    >> Share

  100. DIETER RA, Mattoo A, Hotchkis P, Jaffe IS, et al
    Prophylactic 2-week Glecaprevir/Pibrentasvir in Hepatitis C positive to negative kidney transplantation.
    Nephrol Dial Transplant. 2024 Nov 20:gfae271. doi: 10.1093.
    >> Share

  101. DE HAAN A, Eijgelsheim M, Vogt L, Hoorn EJ, et al
    Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin.
    Nephrol Dial Transplant. 2024 Nov 19:gfae270. doi: 10.1093.
    >> Share

  102. JOO YS, Yun HR, Kim HW, Koh HB, et al
    Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 15:gfae268. doi: 10.1093.
    >> Share

  103. JUDGE PK, Tuttle KR, Staplin N, Hauske SJ, et al
    The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Nov 12:gfae263. doi: 10.1093.
    >> Share

  104. METSARINNE K, Bodegard J, Toppila I, Uusi-Rauva K, et al
    Characteristics, treatment and disease burden among stage 3-4 chronic kidney disease patients with and without type 2 diabetes in Finland during 2016-2022.
    Nephrol Dial Transplant. 2024 Nov 7:gfae242. doi: 10.1093.
    >> Share

  105. ZIMMERMANN S, Mathew A, Bondareva O, Elwakiel A, et al
    Noncanonical microglial IL-1beta maturation in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 4:gfae239. doi: 10.1093.
    >> Share

    October 2024
  106. KRAMER A, Jager KJ, Chesnaye NC, Kerschbaum J, et al
    Changes in the epidemiology of kidney replacement therapy across Europe in 2020-the first year of the COVID-19 pandemic: an ERA Registry study.
    Nephrol Dial Transplant. 2024;39:1835-1845.
    >> Share

  107. NG MSY, Jones AT, Mallett AJ, O'Shaughnessy MM, et al
    Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995 and 2014.
    Nephrol Dial Transplant. 2024;39:1846-1855.
    >> Share

  108. HAMROUN A, Aymes E, Couchoud C, Bechade C, et al
    Elderly predialysis care pathways and early morbidity-mortality upon start of dialysis.
    Nephrol Dial Transplant. 2024 Oct 18:gfae236. doi: 10.1093.
    >> Share

  109. DUARTE MP, Nobrega OT, Vogt BP, Pereira MS, et al
    Reference Values for Handgrip Strength, Five Times Sit-to-stand, and Gait Speed in Patients on Hemodialysis.
    Nephrol Dial Transplant. 2024 Oct 16:gfae232. doi: 10.1093.
    >> Share

  110. COHEN EP, Denic A, Aperna F, Mullan AF, et al
    Stenosis of the glomerulotubular neck in progressive chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 16:gfae234. doi: 10.1093.
    >> Share

  111. WAGNER CA, Massy ZA, Capasso G, Mattace-Raso F, et al
    Translational research on cognitive impairment in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 14:gfae229. doi: 10.1093.
    >> Share

  112. ARDAVANI A, Curtis F, Hopwood E, Highton P, et al
    Effect of pharmacist interventions in chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2024 Oct 9:gfae221. doi: 10.1093.
    >> Share

  113. AN S, Qian H, Yang J, Han C, et al
    Cardiac magnetic resonance assessment of cardiac function across chronic kidney disease stages.
    Nephrol Dial Transplant. 2024 Oct 4:gfae222. doi: 10.1093.
    >> Share

    September 2024
  114. BAE S, Chen Y, Sandal S, Lentine KL, et al
    Association of early steroid withdrawal with kidney transplant outcomes in first-transplant and retransplant recipients.
    Nephrol Dial Transplant. 2024 Sep 30:gfae218. doi: 10.1093.
    >> Share

  115. ZHUANG B, Gan L, Liu B, Yuan W, et al
    Tolerability, safety and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysis.
    Nephrol Dial Transplant. 2024;39:1649-1661.
    >> Share

  116. STEL VS, Boenink R, Astley ME, Boerstra BA, et al
    A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS.
    Nephrol Dial Transplant. 2024;39:1593-1603.
    >> Share

  117. OLIVERAS L, Rosales BM, De La Mata N, Vajdic CM, et al
    Relative survival in patients with cancer and kidney failure.
    Nephrol Dial Transplant. 2024;39:1604-1612.
    >> Share

  118. IATRIDI F, Carrero JJ, Gall EC, Kanbay M, et al
    A commentary from the European Renal Best Practice (ERBP) on the Kidney Disease Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in children and adults.
    Nephrol Dial Transplant. 2024 Sep 19:gfae209. doi: 10.1093.
    >> Share

  119. MAYNE KJ, Sardell RJ, Staplin N, Judge PK, et al
    Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Sep 14:gfae203. doi: 10.1093.
    >> Share

  120. MAHBOOBI S, Mollard R, Tangri N, Askin N, et al
    Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2024 Sep 14:gfae200. doi: 10.1093.
    >> Share

  121. ARANA C, Hermida E, Rovira J, Caro JL, et al
    Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.
    Nephrol Dial Transplant. 2024 Sep 10:gfae186. doi: 10.1093.
    >> Share

  122. VANHOLDER R, Bach D, Davies S, Finne P, et al
    Proactively boosting home dialysis adoption in Europe.
    Nephrol Dial Transplant. 2024 Sep 9:gfae199. doi: 10.1093.
    >> Share

  123. CHO Y, Cullis B, Ethier I, Htay H, et al
    Global structures, practices, and tools for provision of chronic peritoneal dialysis.
    Nephrol Dial Transplant. 2024;39.
    >> Share

  124. HTAY H, Cho Y, Jha V, See E, et al
    Global structures, practices, and tools for provision of hemodialysis.
    Nephrol Dial Transplant. 2024;39.
    >> Share

  125. VIECELLI AK, Gately R, Barday Z, Shojai S, et al
    Worldwide organization and structures for kidney transplantation services.
    Nephrol Dial Transplant. 2024;39.
    >> Share

    August 2024
  126. ZHANG LY, Dinh A, Johansen KL, McCulloch CE, et al
    Access to kidney transplantation from dialysis facilities affiliated with a transplant center versus free-standing dialysis facilities in the US.
    Nephrol Dial Transplant. 2024 Aug 30:gfae194. doi: 10.1093.
    >> Share

  127. ALUND O, Unwin R, Challis B, Kalra PA, et al
    A note on performance metrics for the Kidney Failure Risk Equation.
    Nephrol Dial Transplant. 2024;39:1523-1525.
    >> Share

  128. SACHEZ-ALAMO B, Moi L, Bajema I, Berden A, et al
    Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2024;39:1483-1493.
    >> Share

  129. QUIROGA B, Diez J
    The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines.
    Nephrol Dial Transplant. 2024 Aug 30:gfae193. doi: 10.1093.
    >> Share

  130. PANIAGUA R, Ramos A, Avila M, Ventura MD, et al
    Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events, and hospitalizations: a cluster randomized controlled trial.
    Nephrol Dial Transplant. 2024 Aug 20:gfae188. doi: 10.1093.
    >> Share

  131. SCHROPPEL B, Bettac L, Schulte-Kemna L, Kachele M, et al
    Placement of tunneled hemodialysis catheters - interventional standard.
    Nephrol Dial Transplant. 2024 Aug 16:gfae181. doi: 10.1093.
    >> Share

  132. GROSS O, Boeckhaus J, Weber LT, Heerspink HJL, et al
    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport.
    Nephrol Dial Transplant. 2024 Aug 9:gfae180. doi: 10.1093.
    >> Share

    July 2024
  133. DONG Y, Wang Z, Guo W, Zhu L, et al
    Association between urinary C4d levels and disease progression in IgA nephropathy.
    Nephrol Dial Transplant. 2024;39:1279-1287.
    >> Share

  134. KOMMER A, Kostev K, Schleicher EM, Weinmann-Menke J, et al
    Proton pump inhibitor use and bone fractures in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jul 18:gfae135. doi: 10.1093.
    >> Share

  135. LI Z, Chen S, Tan Y, Lv J, et al
    The effect of preeclampsia on long-term kidney function among pregnant women with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jul 17:gfae172. doi: 10.1093.
    >> Share

  136. MAKHLOUFI M, Cottinet PJ, Ranchin B, Dureuil B, et al
    Hemodialysis versus peritoneal dialysis in children: an eco-audit.
    Nephrol Dial Transplant. 2024 Jul 13:gfae159. doi: 10.1093.
    >> Share

  137. COLLISTER D, Pyne L, Bhasin AA, Smyth B, et al
    Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.
    Nephrol Dial Transplant. 2024 Jul 10:gfae156. doi: 10.1093.
    >> Share

  138. FAGUER S, Serre JE, Brusq C, Bongard V, et al
    A randomized crossover trial of regional anticoagulation modalities for intermittent hemodialysis.
    Nephrol Dial Transplant. 2024 Jul 8:gfae155. doi: 10.1093.
    >> Share

  139. GHIMIRE A, Lloyd AM, Bello AK, Battistella M, et al
    Prescribing patterns and medications costs in patients on maintenance hemodialysis and peritoneal dialysis.
    Nephrol Dial Transplant. 2024 Jul 4:gfae154. doi: 10.1093.
    >> Share

    June 2024
  140. BOGATAJ S, Roelands B, Pajek M, Pajek J, et al
    Intradialytic cycling and cognitive training to mitigate decreased functional and physiological status in haemodialysis patients.
    Nephrol Dial Transplant. 2024;39:1198-1200.
    >> Share

  141. KIM JE, Park J, Jang Y, Kang E, et al
    Oral phosphate binders and incident osteoporotic fracture in patients on dialysis.
    Nephrol Dial Transplant. 2024 Jun 17:gfae139. doi: 10.1093.
    >> Share

  142. HEERSPINK HJL, Agarwal R, Bakris GL, Cherney DZI, et al
    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
    Nephrol Dial Transplant. 2024 Jun 11:gfae132. doi: 10.1093.
    >> Share

    May 2024
  143. BATTAGLIA Y, Mantovani A, Shroff R, Alfano G, et al
    Online haemodiafiltration and all-cause mortality: how fragile are the results of the studies published so far?
    Nephrol Dial Transplant. 2024;39:1034-1036.
    >> Share

  144. LABRIOLA L, Crott R, Desmet C, Romain C, et al
    Infectious complications associated with buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up.
    Nephrol Dial Transplant. 2024;39:1000-1007.
    >> Share

  145. CORTE-IGLESIAS V, Saiz ML, Andrade-Lopez AC, Salazar N, et al
    Propionate and butyrate counteract renal damage and progression to chronic kidney disease.
    Nephrol Dial Transplant. 2024 May 24:gfae118. doi: 10.1093.
    >> Share

  146. VANHOLDER R, Bach D, Davies S, Finne P, et al
    Unlocking the Untapped Potential: The Neglected Home Dialysis Assets in Europe.
    Nephrol Dial Transplant. 2024 May 16:gfae111. doi: 10.1093.
    >> Share

  147. KREMER D, Salamah S, Groothof D, Post A, et al
    Plasma Symmetric Dimethylarginine and Kidney Graft Function in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2024 May 15:gfae109. doi: 10.1093.
    >> Share

  148. MCEWAN P, Gabb PD, Davis JA, Sanchez JJG, et al
    The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
    Nephrol Dial Transplant. 2024 May 10:gfae106. doi: 10.1093.
    >> Share

  149. KRAMER A, Boenink R, Mercado Vergara CG, Bell S, et al
    Time trends in preemptive kidney transplantation in Europe: an era registry study.
    Nephrol Dial Transplant. 2024 May 9:gfae105. doi: 10.1093.
    >> Share

  150. IATRIDI F, Malandris K, Ekart R, Xagas E, et al
    Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study.
    Nephrol Dial Transplant. 2024 May 6:gfae104. doi: 10.1093.
    >> Share

    April 2024
  151. WOLFGRAM DF, Richerson WT, Murray AM, Schmit BD, et al
    Cognitive deficits associate with cerebral hypoxia during hemodialysis.
    Nephrol Dial Transplant. 2024 Apr 30:gfae101. doi: 10.1093.
    >> Share

  152. LEMOINE S, Akbari A, Brahm G, Dorie J, et al
    Redefining the concept of residual renal function with kidney sodium MRI: a pilot study.
    Nephrol Dial Transplant. 2024 Apr 30:gfae070. doi: 10.1093.
    >> Share

  153. KANBAY M, Basile C, Battaglia Y, Mantovani A, et al
    Shared decision making in elderly patients with kidney failure.
    Nephrol Dial Transplant. 2024;39:742-751.
    >> Share

  154. LIAO YR, Tsai YC, Hsieh TH, Tsai MT, et al
    FHL2 in arterial medial calcification in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Apr 25:gfae091. doi: 10.1093.
    >> Share

  155. LOMBARDI G, Ferraro PM, De Tomi E, Bargagli M, et al
    Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate.
    Nephrol Dial Transplant. 2024 Apr 17:gfae087. doi: 10.1093.
    >> Share

  156. ZHANG X, Wang G, Li M, Li Y, et al
    Both partial inactivation as well as activation of NF-kappaB signaling lead to hypertension and chronic kidney disease.
    Nephrol Dial Transplant. 2024 Apr 13:gfae090. doi: 10.1093.
    >> Share


  157. Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.
    Nephrol Dial Transplant. 2024 Apr 10:gfae073. doi: 10.1093.
    >> Share

  158. STOUMPOS S, Crowe K, Sarafidis P, Barratt J, et al
    Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
    Nephrol Dial Transplant. 2024 Apr 4:gfae075. doi: 10.1093.
    >> Share

    March 2024
  159. ELEFTHERIADIS G, Naik MG, Osmanodja B, Halleck F, et al
    Office or home versus 24-hour blood pressure measurement in stable kidney transplant recipients.
    Nephrol Dial Transplant. 2024 Mar 28:gfae076. doi: 10.1093.
    >> Share

  160. WINDAHL K, Chesnaye NC, Irving GF, Stenvinkel P, et al
    The safety of a low protein diet in older adults with advanced chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 27:gfae077. doi: 10.1093.
    >> Share

  161. FORBES AK, Hinton W, Feher MD, Elson W, et al
    A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
    Nephrol Dial Transplant. 2024 Mar 22:gfae071. doi: 10.1093.
    >> Share

  162. VALENZUELA PL, Castillo-Garcia A, Saco-Ledo G, Santos-Lozano A, et al
    Physical exercise: a polypill against chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 9:gfae062. doi: 10.1093.
    >> Share

  163. ZHAI S, Liu D, Liu H, Li W, et al
    Cold atmospheric plasma for chronic kidney disease-related skin disorders.
    Nephrol Dial Transplant. 2024 Mar 1:gfae057. doi: 10.1093.
    >> Share

    February 2024
  164. VAN OEVELEN M, Bonenkamp AA, van Eck van der Sluijs A, Bos WJW, et al
    Health-related quality of life and symptom burden in patients on haemodialysis.
    Nephrol Dial Transplant. 2024;39:436-444.
    >> Share

  165. AKERBOOM B, Janse RJ, Caldinelli A, Lindholm B, et al
    A tool to predict the risk of lower extremity amputation in patients starting dialysis.
    Nephrol Dial Transplant. 2024 Feb 26:gfae050. doi: 10.1093.
    >> Share

  166. KUNUTSOR SK, Dey RS, Touw DJ, Bakker SJL, et al
    Urine cotinine versus self-reported smoking and the risk of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Feb 24:gfae054. doi: 10.1093.
    >> Share

  167. VERZOLA D, Saio M, Milanesi S, Picciotto D, et al
    Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Feb 23:gfae051. doi: 10.1093.
    >> Share

  168. ADOLI LK, Couchoud C, Chatelet V, Lobbedez T, et al
    Lower access to kidney transplantation for women in France is not explained by comorbidities and social deprivation.
    Nephrol Dial Transplant. 2024 Feb 21:gfae047. doi: 10.1093.
    >> Share

    November 2023
  169. DE LA MATA NL, Khou V, Hedley JA, Kelly PJ, et al
    Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist.
    Nephrol Dial Transplant. 2023 Nov 28:gfad253. doi: 10.1093.
    >> Share

  170. HARDING JL, Di M, Pastan SO, Doucet N, et al
    Examination of Sex/Gender Disparities Across the Continuum of Kidney Transplant Steps.
    Nephrol Dial Transplant. 2023 Nov 9:gfad242. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016